2006
DOI: 10.1016/j.jviromet.2006.03.019
|View full text |Cite
|
Sign up to set email alerts
|

Detection of antibodies to avian infectious bronchitis virus by a recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay

Abstract: The recombinant antigen obtained by cloning and expressing two IBV nucleocapsid protein fragments (143-414 aa, 281-414 aa) in Escherichia coli was used for the detection of avian infectious bronchitis virus (IBV) specific antibodies in chicken sera by the indirect ELISA (rNpIBV-ELISA). As a result of testing 1524 serum samples the diagnostic sensitivity and specificity of rNpIBV-ELISA when comparing those of the routine whole IBV ELISA have been shown to be 93.81% and 87.36%, respectively. The agreement value … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
15
0
8

Year Published

2011
2011
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(23 citation statements)
references
References 13 publications
0
15
0
8
Order By: Relevance
“…As was previously documented, most serological studies including the IDEXX ELISA kit use viral particles of IBV as an antigen for detection of IBV infection. However, preparation of purified virions for use as an ELISA coating antigen is time-consuming and expensive, while recombinant protein expressed in vitro has more advantages as serodiagnostic antigen that it allow better standardization of the tests, reduce the costs of production and purification, and is easy to prepare with large amount (Lugovskaya et al, 2006). In this study, we used GST-fused nsp5 expressed by E. coli as the coating antigen to establish an nsp5-ELISA to detect IBV antibody.…”
Section: Discussionmentioning
confidence: 99%
“…As was previously documented, most serological studies including the IDEXX ELISA kit use viral particles of IBV as an antigen for detection of IBV infection. However, preparation of purified virions for use as an ELISA coating antigen is time-consuming and expensive, while recombinant protein expressed in vitro has more advantages as serodiagnostic antigen that it allow better standardization of the tests, reduce the costs of production and purification, and is easy to prepare with large amount (Lugovskaya et al, 2006). In this study, we used GST-fused nsp5 expressed by E. coli as the coating antigen to establish an nsp5-ELISA to detect IBV antibody.…”
Section: Discussionmentioning
confidence: 99%
“…The spike protein, a viral surface glycoprotein, was shown to induce neutralizing antibody response, and the nucleocpasid protein was shown to elicit strong antibody responses [2,5]. Despite the presence and application of IBV vaccines in poultry, there is a high rate of emergence of antigenic variants and recombinant strains, and the lack of cross-protection between different viral genotypes, making disease control difficult and vaccine development rather challenging [15,16]. Therefore, genetic characterization of circulating strains of IBV, appropriate vaccination programs, and application of sensitive diagnostic tests to detect and assess disease risk are important regional, national, and international strategies to control IBV infections [2,8,10,21,23].…”
Section: Introductionmentioning
confidence: 99%
“…Several ELISAs have been developed for detection of antibodies to IBV in chickens. Recombinant antigens used in these ELISAs were either based on the S1 protein [20], which is highly variable, or the N protein and often produced in an E. coli expression system [15]. E. coli is a common flora or pathogen in chickens, thus creating the possibility of serological cross-reactivity and detection of false positives in these diagnostic assays.…”
Section: Introductionmentioning
confidence: 99%
“…The reaction antigen may be either whole virion or recombinant subunits. In previous works, recombinant spike (Wang et al, 2002) and nucleocapsid protein (Chen et al, 2003;Lugovskaya et al, 2006) expressed in bacteria or insect cells have been used as a coating antigen to improve the efficacy of detection. In addition, an ELISA specific to IBV-IgM was described to detect an early infection (De Wit et al, 1998).…”
Section: Introductionmentioning
confidence: 99%